Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca launches diabetes portal in Germany

Zuckerkrank.de is designed to educate patients and families
zuckerkrank_de_start_astrazeneca

AstraZeneca has launched a new online portal for patients and families to learn about living with type 2 diabetes.

Zuckerkrank.de has information on treatment options and outlines how type 2 diabetes patients can use exercise and diet to improve the likelihood of successful treatment.

Visitors to the site can download a nutrition guide, for example. This includes examples of food labelled according to the traffic light system.

Tips and practical advice for everyday life with type 2 diabetes are also available, as well as a range of materials and advice from experts. Other features of the portal include information on treatment options and individual treatment levels.

Topics covered include diabetes and mental health, and separate sections on the site outline diabetes-related events and links to other useful information sources.

Patients will also find information on diabetes care during pregnancy, and how best to maintain their blood sugar levels when travelling, for example.

Advice is also given on how to manage careers while coping with type 2 diabetes and its symptoms. The site explains, for instance, whether sufferers are obliged to disclose the condition when applying for jobs, and lists roles unsuited to people at risk from hypoglycaemia.

Type 2 diabetes is a priority area for AstraZeneca and the company's Diabetic Initiative in Germany aims to inform people about the disease while supporting those affected. The new portal is the first step in this awareness campaign.

19th August 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics